ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Athira Pharma Inc

Athira Pharma Inc (ATHA)

0,603
-0,0186
(-2,99%)
Geschlossen 12 Dezember 10:00PM
0,603
0,00
(0,00%)
Nach Börsenschluss: 1:40AM

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
0,603
Gebot
0,603
Fragen
0,63
Volumen
308.888
0,604 Tagesbereich 0,629
0,4115 52-Wochen-Bereich 4,2984
Marktkapitalisierung
Handelsende
0,6216
Handelsbeginn
0,6121
Letzte Trade
1
@
0.6222
Letzter Handelszeitpunkt
Finanzvolumen
US$ 190.408
VWAP
0,61643
Durchschnittliches Volumen (3 Mio.)
5.036.582
Ausgegebene Aktien
38.669.073
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,20
Gewinn pro Aktie (EPS)
-3,04
Erlöse
1,63M
Nettogewinn
-117,67M

Über Athira Pharma Inc

Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease. Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease.

Sektor
Biological Pds,ex Diagnstics
Branche
Biological Pds,ex Diagnstics
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Athira Pharma Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ATHA. The last closing price for Athira Pharma was US$0,62. Over the last year, Athira Pharma shares have traded in a share price range of US$ 0,4115 to US$ 4,2984.

Athira Pharma currently has 38.669.073 shares in issue. The market capitalisation of Athira Pharma is US$24,04 million. Athira Pharma has a price to earnings ratio (PE ratio) of -0.20.

ATHA Neueste Nachrichten

Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND

BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health...

Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates

BOTHELL, Wash., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health...

Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Meeting

BOTHELL, Wash., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical stage biopharmaceutical company focused on developing small molecules to restore neuronal health...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0343-5.382080652750.63730.66790.60273865960.6265898CS
4-0.132951-18.06519727540.7359510.810.63919410.65475942CS
120.102820.55177928830.50020.82640.411550365820.60673782CS
26-1.927-76.16600790512.533.670.411526671140.67417099CS
52-1.337-68.91752577321.944.29840.411515037030.90559097CS
156-12.847-95.516728624513.4514.220.41157365102.08122118CS
260-19.347-96.97744360919.9534.790.41156778215.14217409CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
LAESSEALSQ Corporation
US$ 1,1406
(99,75%)
225,46M
AMPGAmplitech Group Inc
US$ 1,9001
(91,52%)
201,88M
CADLCandel Therapeutics Inc
US$ 7,7401
(67,90%)
100,61M
JZXNJiuzi Holdings Inc
US$ 1,792
(60,00%)
2,56M
LDTCLeddarTech Holdings Inc
US$ 1,81
(49,59%)
75,14M
SFHGSamfine Creation Holdings Group Ltd
US$ 3,04
(-85,59%)
10,28M
CLRBCellectar Biosciences Inc
US$ 0,3039
(-76,26%)
38,21M
QTTBQ32 Bio Inc
US$ 6,0291
(-75,30%)
3,44M
TFFPTFF Pharmaceuticals Inc
US$ 0,1639
(-45,78%)
3,54M
MARXMars Acquisition Corporation
US$ 7,24
(-33,33%)
55,08k
RGTIRigetti Computing Inc
US$ 7,38
(13,71%)
307,29M
LAESSEALSQ Corporation
US$ 1,1406
(99,75%)
223,51M
AMPGAmplitech Group Inc
US$ 1,9001
(91,52%)
200,45M
NVDANVIDIA Corporation
US$ 139,31
(3,14%)
182,44M
LCIDLucid Group Inc
US$ 2,44
(3,39%)
110,58M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock